Loomis, Sayles & Company’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-90
| Closed | -$10K | – | 900 |
|
|
2018
Q2 | $10K | Hold |
90
| – | – | ﹤0.01% | 794 |
|
|
2018
Q1 | $7K | Sell |
90
-617
| -87% | -$48K | ﹤0.01% | 837 |
|
|
2017
Q4 | $41K | Buy |
707
+21
| +3% | +$1.22K | ﹤0.01% | 622 |
|
|
2017
Q3 | $32K | Buy |
686
+51
| +8% | +$2.38K | ﹤0.01% | 675 |
|
|
2017
Q2 | $23K | Buy |
635
+57
| +10% | +$2.07K | ﹤0.01% | 746 |
|
|
2017
Q1 | $18K | Sell |
578
-61
| -10% | -$1.9K | ﹤0.01% | 774 |
|
|
2016
Q4 | $21K | Buy |
639
+231
| +57% | +$7.59K | ﹤0.01% | 773 |
|
|
2016
Q3 | $11K | Buy |
408
+85
| +26% | +$2.29K | ﹤0.01% | 748 |
|
|
2016
Q2 | $7K | Buy |
323
+256
| +382% | +$5.55K | ﹤0.01% | 793 |
|
|
2016
Q1 | $2K | Buy |
+67
| New | +$2K | ﹤0.01% | 990 |
|